These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 18632046)

  • 1. Screening for type 2 diabetes in primary care using a stepwise protocol: the Diabscreen study.
    Klein Woolthuis EP; de Grauw WJ; van Gerwen WH; van den Hoogen HJ; van de Lisdonk EH; Metsemakers JF; van Weel C
    Prim Care Diabetes; 2007 Dec; 1(4):199-202. PubMed ID: 18632046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of screening for diabetes mellitus in dental health care.
    Engström S; Berne C; Gahnberg L; Svärdsudd K
    Diabet Med; 2013 Feb; 30(2):239-45. PubMed ID: 22946629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of undiagnosed Type-2-diabetes mellitus and impaired fasting glucose in German primary care: data from the German Metabolic and Cardiovascular Risk Project (GEMCAS).
    Hauner H; Hanisch J; Bramlage P; Steinhagen-Thiessen E; Schunkert H; Jöckel KH; Wasem J; Moebus S
    Exp Clin Endocrinol Diabetes; 2008 Jan; 116(1):18-25. PubMed ID: 17926235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can a screening programme for diabetes be applied to another population?
    Glümer C; Borch-Johnsen K; Colagiuri S
    Diabet Med; 2005 Sep; 22(9):1234-8. PubMed ID: 16108854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A type 2 diabetes screening program by general practioners in a Belgian at risk population.
    Buysschaert M; Vandenbroucke C; Barsoum S
    Diabetes Metab; 2001 Apr; 27(2 Pt 1):109-14. PubMed ID: 11353875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiometabolic profile of people screened for high risk of type 2 diabetes in a national diabetes prevention programme (FIN-D2D).
    Saaristo T; Moilanen L; Jokelainen J; Korpi-Hyövälti E; Vanhala M; Saltevo J; Niskanen L; Peltonen M; Oksa H; Cederberg H; Tuomilehto J; Uusitupa M; Keinänen-Kiukaanniemi S
    Prim Care Diabetes; 2010 Dec; 4(4):231-9. PubMed ID: 21134669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for Type 2 diabetes in the accident and emergency department.
    George PM; Valabhji J; Dawood M; Henry JA
    Diabet Med; 2005 Dec; 22(12):1766-9. PubMed ID: 16401327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Higher prevalence of risk factors for type 2 diabetes mellitus and subsequent higher incidence in men.
    Almdal T; Scharling H; Jensen JS; Vestergaard H
    Eur J Intern Med; 2008 Jan; 19(1):40-5. PubMed ID: 18206600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Point-of-care testing as a tool for screening for diabetes and pre-diabetes.
    Rush E; Crook N; Simmons D
    Diabet Med; 2008 Sep; 25(9):1070-5. PubMed ID: 19183312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normal fasting plasma glucose levels and type 2 diabetes in young men.
    Tirosh A; Shai I; Tekes-Manova D; Israeli E; Pereg D; Shochat T; Kochba I; Rudich A;
    N Engl J Med; 2005 Oct; 353(14):1454-62. PubMed ID: 16207847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Yield of opportunistic targeted screening for type 2 diabetes in primary care: the diabscreen study.
    Klein Woolthuis EP; de Grauw WJ; van Gerwen WH; van den Hoogen HJ; van de Lisdonk EH; Metsemakers JF; van Weel C
    Ann Fam Med; 2009; 7(5):422-30. PubMed ID: 19752470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Detection of a previously unrecognized type 2 diabetes using a risk questionnaire. Efficiency for general population screening].
    Scherbaum WA; Dicken HD; Verheyen F; Baehring T
    Dtsch Med Wochenschr; 2006 Oct; 131(40):2208-12. PubMed ID: 17021988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence of impaired glucose metabolism in Hispanics with two or more risk factors for metabolic syndrome in the primary care setting.
    Neira CP; Hartig M; Cowan PA; Velasquez-Mieyer PA
    J Am Acad Nurse Pract; 2009 Mar; 21(3):173-8. PubMed ID: 19302694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired fasting glucose cutoff value of 5.6 mmol/l combined with other cardiovascular risk markers is a better predictor for incident Type 2 diabetes than the 6.1 mmol/l value: Tehran lipid and glucose study.
    Harati H; Hadaegh F; Tohidi M; Azizi F
    Diabetes Res Clin Pract; 2009 Jul; 85(1):90-5. PubMed ID: 19414206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Detection of non-insulin-dependent diabetes mellitus in asymptomatic adults].
    Díaz Campos R; de la Garza O; Cortés J; Forsbach G; Sánchez V; Palmeros CI
    Rev Invest Clin; 1993; 45(6):553-7. PubMed ID: 8159875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discover diabetes: screening for diabetes mellitus in the Waikato.
    Lawrenson RA; Dunn PJ; Jury D; Sceats J
    N Z Med J; 1993 Dec; 106(969):522-4. PubMed ID: 8183493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency of abnormal carbohydrate metabolism and diabetes in a population-based screening of adolescents.
    Dolan LM; Bean J; D'Alessio D; Cohen RM; Morrison JA; Goodman E; Daniels SR
    J Pediatr; 2005 Jun; 146(6):751-8. PubMed ID: 15973311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asymptomatic diabetes: the difference between population-based and office-based screening.
    Adam FM; Adam JM; Pandeleki N; Mappangara I
    Acta Med Indones; 2006; 38(2):67-71. PubMed ID: 16799205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Five-year predictive factors of type 2 diabetes in men with impaired fasting glucose.
    Lecomte P; Vol S; Cacès E; Born C; Chabrolle C; Lasfargues G; Halimi JM; Tichet J
    Diabetes Metab; 2007 Apr; 33(2):140-7. PubMed ID: 17320447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevalence of newly diagnosed type 2 diabetes, impaired glucose tolerance and abnormal fasting glucose in a high risk population. Data from the RIAD study using new diagnostic criteria for diabetes].
    Köhler C; Temelkova-Kurktschiev T; Schaper F; Fücker K; Hanefeld M
    Dtsch Med Wochenschr; 1999 Sep; 124(37):1057-61. PubMed ID: 10520305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.